Your browser doesn't support javascript.
The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres.
Gatellier, Laureline; Shankar, Abhishek; Dewi, Luh K Mela; Hussain, Quazi Mushtaq; Dendup Wangdi, Tashi; Sukumaran, Dato Babu; Sari, Nina Kemala; Tavakkoli Shiraji, Sahar; Biglari, Mohammad; Tahmasebi, Mamak; Iwata, Satoshi; Suzuki, Tatsuya; Myung, Seung-Kwon; Chun, June Young; Han, Jong Soo; Lau, Fen Nee; Yusak, Suhana; Bayarsaikhan, Luvsandorj; Mu, Khin Thin; Pradhananga, Kishore K; Yusuf, Aasim; Lin, Ching-Hung; Chiang, Ruru Chun-Ju; Sangrajran, Suleeporn; Nguyen, Quang Tien; Huong, Giang Nguyen; Soe, Aung Naing; Sharma, D N; Sengar, Manju; Pramesh, C S; Matsuda, Tomohiro; Jarrahi, Alireza Mosavi; Hwang, William.
  • Gatellier L; National Cancer Center, Tokyo, Japan.
  • Shankar A; Lady Hardinge Medical College & Associated Hospitals, Delhi, India.
  • Dewi LKM; Dharmais Hospital - National Cancer Center, Jakarta, Indonesia.
  • Hussain QM; National Institute of Cancer Research and Hospital, Dhaka, Bangladesh.
  • Dendup Wangdi T; JDWNR Hospital Thimphu University of Medical Sciences, Bhutan.
  • Sukumaran DB; The Brunei Cancer Centre, Brunei Darussalam.
  • Sari NK; Dharmais Hospital - National Cancer Center, Jakarta, Indonesia.
  • Tavakkoli Shiraji S; Hematology, Oncology and Bone Marrow transplantation Research Center, Shariati Hospital, Tehran University of Medical Science,Tehran, Iran.
  • Biglari M; Hematology, Oncology and Bone Marrow transplantation Research Center, Shariati Hospital, Tehran University of Medical Science,Tehran, Iran.
  • Tahmasebi M; Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Iwata S; National Cancer Center, Tokyo, Japan.
  • Suzuki T; National Cancer Center, Tokyo, Japan.
  • Myung SK; National Cancer Center of Korea, Goyang-si Gyeonggi-do, Republic of Korea.
  • Chun JY; National Cancer Center of Korea, Goyang-si Gyeonggi-do, Republic of Korea.
  • Han JS; National Cancer Center of Korea, Goyang-si Gyeonggi-do, Republic of Korea.
  • Lau FN; National Cancer Institute, Putrajaya, Malaysia.
  • Yusak S; National Cancer Institute, Putrajaya, Malaysia.
  • Bayarsaikhan L; National Cancer Center of Mongolia, Ulaanbaatar, Mongolia.
  • Mu KT; Myanmar Yangon General Hospital, Yangon, Myanmar.
  • Pradhananga KK; Kathmandu Cancer Center, Bhaktapur, Nepal.
  • Yusuf A; Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan.
  • Lin CH; National Taiwan University Cancer Center Hospital, Taipei City, Taiwan.
  • Chiang RC; Taiwan Cancer Registry, and Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
  • Sangrajran S; National Cancer Institute, Bangkok, Thailand.
  • Nguyen QT; National Cancer Institute, National Cancer Hospital, Hanoi, Vietnam.
  • Huong GN; National Cancer Institute, National Cancer Hospital, Hanoi, Vietnam.
  • Soe AN; City Cancer Challenge Foundation, Geneva, Switzerland.
  • Sharma DN; Dr BR Ambedkar Institute Rotary Cancer Hospital & National Cancer Institute, All India Institute of Medical Sciences, Delhi, India.
  • Sengar M; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Pramesh CS; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Matsuda T; National Cancer Center, Tokyo, Japan.
  • Jarrahi AM; Medical School, Shahid Behshti University of Medical Sciences, Tehran, Iran.
  • Hwang W; National Cancer Centre, Singapore.
Asian Pac J Cancer Prev ; 22(3): 681-690, 2021 Mar 01.
Article in English | MEDLINE | ID: covidwho-1155072
ABSTRACT

OBJECTIVE:

The COVID-19 pandemic has dramatically affected healthcare services around Asia. The Asian National Cancer Centres Alliance and the Asia-Pacific Organisation for Cancer Prevention collaborated to assess the mid- and long- term impact of COVID-19 to cancer care in Asia.

METHODS:

The two entities organised a combined symposium and post-meeting interactions among representatives of major cancer centres from seventeen Asian countries to outlining major challenges and countermeasures.

RESULTS:

Participating stakeholders distilled five big questions. 1) "Will there be an explosion of late-stage cancers after the pandemic?" To address and recover from perceived delayed prevention, screening, treatment and care challenges, collaboration of key stakeholders in the region and alignment in cancer care management, policy intervention and cancer registry initiatives would be of essential value. 2) "Operations and Finance" The pandemic has resulted in significant material and financial casualties. Flagged acute challenges (shortages of supplies, imposition of lockdown) as well as longer-standing reduction of financial revenue, manpower, international collaboration, and training should also be addressed. 3) "Will telemedicine and technological innovations revolutionize cancer care?" Deploying and implementing telemedicine such as teleconsultation and virtual tumour boards were considered invaluable. These innovations could become a new regular practice, leading to expansion of tele-collaboration through collaboration of institutions in the region. 4) "Will virtual conferences continue after the pandemic?" Virtual conferences during the pandemic have opened new doors for knowledge sharing, especially for representatives of low- and middle-income countries in the region, while saving time and costs of travel. 5) "How do we prepare for the next pandemic or international emergency?" Roadmaps for action to improve access to appropriate patient care and research were identified and scrutinised.

CONCLUSION:

Through addressing these five big questions, focused collaboration among members and with international organisations such as City Cancer Challenge will allow enhanced preparedness for future international emergencies.
.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cancer Care Facilities / Telemedicine / COVID-19 / Neoplasms Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Asian Pac J Cancer Prev Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: Apjcp.2021.22.3.681

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cancer Care Facilities / Telemedicine / COVID-19 / Neoplasms Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Asian Pac J Cancer Prev Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: Apjcp.2021.22.3.681